menu search

ZVSA / Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?
ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering. The stock offering announced by ZyVersa Therapeutics covers securities offered by Selling Securityholders. Read More
Posted: Feb 2 2023, 08:08
Author Name: InvestorPlace
Views: 082899

ZVSA News  

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase

By GlobeNewsWire
April 11, 2023

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase

WESTON, Fla., April 11, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceut more_horizontal

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?

By InvestorPlace
March 23, 2023

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?

ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is taking off on Thursday without any recent news from the biopharmaceutical company. Instead, it looks lik more_horizontal

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?

By InvestorPlace
February 2, 2023

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?

ZyVersa Therapeutics (NASDAQ: ZVSA ) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering. The stock more_horizontal

ZyVersa Therapeutics to Present at BIO CEO & Investor Conference

By GlobeNewsWire
January 25, 2023

ZyVersa Therapeutics to Present at BIO CEO & Investor Conference

WESTON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceuti more_horizontal

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at the Virtual Investor 2023 Companies to Watch Event

By GlobeNewsWire
January 11, 2023


Search within

Pages Search Results: